BUSPIRONE 5 MG
BUSPIRONE HYDROCHLORIDE : 5 MG · DIN 02207664 · APOTEX INC
Health Canada status: APPROVED
What is BUSPIRONE?
BUSPIRONE 5 MG contains BUSPIRONE HYDROCHLORIDE : 5 MG. It is listed in the Health Canada Drug Product Database under DIN 02207664, held by APOTEX INC, supplied as TABLET for ORAL administration. Health Canada currently lists it as approved, status dated 18-Dec-2020. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02207664 |
|---|---|
| Brand name | BUSPIRONE |
| Generic / active ingredient | BUSPIRONE HYDROCHLORIDE : 5 MG |
| Manufacturer | APOTEX INC |
| Strength | 5 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | N05BE01 BUSPIRONE |
| AHFS class | 28:24.92 |
| Biosimilar | No |
| Health Canada status | APPROVED |
| Status date | 18-Dec-2020 |
Is BUSPIRONE in shortage in Canada?
A Canadian shortage report is on file for a product containing this molecule: Active — reported by SANIS HEALTH INC, last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Other Canadian products sharing ATC code N05BE01 BUSPIRONE. 7 of 25 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| AMB-BUSPIRONE | 10 MG | TABLET | AMBICARE PHARMACEUTICALS INC. | MARKETED | DIN 02550555 |
| AURO-BUSPIRONE | 10 MG | TABLET | AURO PHARMA INC | MARKETED | DIN 02500213 |
| JAMP BUSPIRONE | 10 MG | TABLET | JAMP PHARMA CORPORATION | MARKETED | DIN 02509911 |
| MINT-BUSPIRONE | 10 MG | TABLET | MINT PHARMACEUTICALS INC | MARKETED | DIN 02519054 |
| PMS-BUSPIRONE | 10 MG | TABLET | PHARMASCIENCE INC | MARKETED | DIN 02230942 |
| PRO-BUSPIRONE | 10 MG | TABLET | PRO DOC LIMITEE | MARKETED | DIN 02223163 |
| TEVA-BUSPIRONE | 10 MG | TABLET | TEVA CANADA LIMITED | MARKETED | DIN 02231492 |
| APO-BUSPIRONE | 10 MG | TABLET | APOTEX INC | DORMANT | DIN 02211076 |
| BUSPAR TAB 10MG | 10 MG | TABLET | BRISTOL-MYERS SQUIBB CANADA | CANCELLED POST MARKET | DIN 00603821 |
| BUSPIRONE | 10 MG | TABLET | APOTEX INC | APPROVED | DIN 02207672 |
Who else supplies BUSPIRONE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. BUSPIRONE appears in 15 registered pack listings across 4 markets, published on 3 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
This product is approved by Health Canada but not yet marketed in Canada, so there is no Canadian supply to draw on today. Nexara can tell you whether it has been launched, and can look at supply from other markets where a Canadian pack is not required or where importation is permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.